Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Show me how to use this page

Alcon AG Stock

Price
Target price
€54.00

€54.00

2.230%
-
2.230%
€72.73
 
09.10.23 / Tradegate WKN: A2PDXE / Name: Alcon / Stock / ? / We currently do not receive price updates for this security
Please give a prediction to see the opinions of the community
Buy
None
Sell
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of Alcon AG in the next few years
Wizard

Financial data and news for Alcon

sharewise wants to provide you with the best news and tools for Alcon, so we directly link to the best financial data sources.

Financials

News

Broker

 

News

Alcon Canada Launches TOTAL30 Multifocal Contact Lenses for Reusable Lens Patients with Presbyopia: https://mms.businesswire.com/media/20240131400399/en/2016416/5/Total_30_Multifocal_MF_Pack_Shot.jpg
Alcon Canada Launches TOTAL30 Multifocal Contact Lenses for Reusable Lens Patients with Presbyopia


Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced the launch of TOTAL30® Multifocal in Canada, the first and only monthly Water Gradient multifocal

BusinessWire_EN 
0 01.02.24
Alcon Reports Strong First-Quarter 2024 Results Driven by Robust Sales in Contact Lenses and Ocular Health: https://mms.businesswire.com/media/20200714005390/en/717676/5/Alcon_CMYK_Tag.jpg
Alcon Reports Strong First-Quarter 2024 Results Driven by Robust Sales in Contact Lenses and Ocular Health


Alcon (SIX/NYSE:ALC), the global leader in eye care, reported its financial results for the three months ended March 31, 2024. For the first quarter of 2024, sales were $2.4 billion, an increase of

BusinessWire_EN 
0 13.05.24
Alcon Announces Results of 2024 Annual General Meeting: https://mms.businesswire.com/media/20200714005390/en/717676/5/Alcon_CMYK_Tag.jpg
Alcon Announces Results of 2024 Annual General Meeting


Alcon Inc. (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the approval of all proposed binding resolutions at its 2024 Annual General

BusinessWire_EN 
0 08.05.24
Alcon Publishes Agenda for 2024 Annual General Meeting: https://mms.businesswire.com/media/20200714005390/en/717676/5/Alcon_CMYK_Tag.jpg
Alcon Publishes Agenda for 2024 Annual General Meeting


Alcon (SIX/NYSE: ALC), the global leader in eye care, will hold its Annual General Meeting (AGM) on May 8, 2024.



Alcon is pleased to welcome shareholders to its second in-person AGM since

BusinessWire_EN 
0 08.04.24
Alcon Strengthens Leadership in IOL Innovation with the launch of the Clareon Presbyopia Correcting IOLs in India: https://mms.businesswire.com/media/20200714005390/en/717676/5/Alcon_CMYK_Tag.jpg
Alcon Strengthens Leadership in IOL Innovation with the launch of the Clareon Presbyopia Correcting IOLs in India


Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the launch of the Clareon® Family of intraocular lenses (IOLs) in India. Utilizing

BusinessWire_EN 
0 12.03.24
Vivity, the World’s Leading EDOF IOL, Reaches One Million Milestone: https://mms.businesswire.com/media/20200714005390/en/717676/5/Alcon_CMYK_Tag.jpg
Vivity, the World’s Leading EDOF IOL, Reaches One Million Milestone


Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today proudly announces AcrySof® IQ Vivity® and Clareon® Vivity extended depth of focus (EDOF)

BusinessWire_EN 
0 06.03.24
Vivity, the World’s Leading EDOF IOL, Reaches One Million Milestone: https://mms.businesswire.com/media/20200714005390/en/717676/5/Alcon_CMYK_Tag.jpg
Vivity, the World’s Leading EDOF IOL, Reaches One Million Milestone


Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today proudly announces AcrySof® IQ Vivity® and Clareon® Vivity extended depth of focus (EDOF)

BusinessWire_EN 
0 06.03.24
Alcon's Broad Portfolio Delivers Robust Sales and Earnings Growth in FY 2023: https://mms.businesswire.com/media/20200714005390/en/717676/5/Alcon_CMYK_Tag.jpg
Alcon's Broad Portfolio Delivers Robust Sales and Earnings Growth in FY 2023


Alcon (SIX/NYSE:ALC), the global leader in eye care, reported its financial results for the three and twelve months ended December 31, 2023. For the fourth quarter of 2023, sales were $2.3 billion

BusinessWire_EN 
0 27.02.24
Alcon Announces Positive Topline Results From Phase 3 COMET Trials of AR-15512, a Novel Topical Drug Candidate for Dry Eye: https://mms.businesswire.com/media/20200714005390/en/717676/5/Alcon_CMYK_Tag.jpg
Alcon Announces Positive Topline Results From Phase 3 COMET Trials of AR-15512, a Novel Topical Drug Candidate for Dry Eye


Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced positive topline results from the two pivotal Phase 3 clinical trials (COMET-2 and

BusinessWire_EN 
0 09.01.24
Alcon to Present at 2024 Annual J.P. Morgan Healthcare Conference : https://mms.businesswire.com/media/20200714005390/en/717676/5/Alcon_CMYK_Tag.jpg
Alcon to Present at 2024 Annual J.P. Morgan Healthcare Conference


Alcon (SIX/NYSE: ALC) CEO David Endicott will present at the 2024 J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024, at 3:00 p.m. PST.



A live webcast of the conference will be

BusinessWire_EN 
0 27.12.23